Breaking news and analysis from the U.S. and around the world at WSJ.com. Politics, Economics, Markets, Life & Arts, and in-depth reporting.

It has lagged broader equities so far this year.

CRISPR Therapeutics owns the only approved gene therapy of its kind, yet the stock sits far below where Wall Street thinks it belongs. One analyst sees a path to gains that would embarrass the broader market,

Investors shrug off AI safety concerns and Iran war, sending market to a new peak.

Some prominent bankers are asking the global finance industry not to let AI overshadow talks about reducing planet-warming pollution.

Meta launched an AI agent that books travel without a middleman, and the entire online travel sector sold off hard. Whether Airbnb belongs in that selloff depends on a single question about who actually owns the supply.

FTSE 100 up 113 points at 10,773 Wall Street headed for a positive start Miners and banks lead blue-chip gains Oil producers fall as crude retreats 4:15pm: Nasdaq reaches all-time high Optimism returned to Wall Street on Monday,

Trump's crackdown on three news outlets hits a legal roadblock. OpenAI faces scrutiny after AI agent accesses Australian government files. A key U.S.-China trade deadline pushed back.

Bernstein cut its 2030 gold price target to $5,600 from $6,100 but stayed bullish as central bank demand offsets rising real rates and Fed rate hikes.

Stocks have been getting help from the recent decline in oil prices, although they rose in Asian trading. In energy trading, benchmark U.S. crude gained 0.43% to $96.19 a barrel. Brent, the international standard, rose 0.65% to $100.99 a barrel.

Oracle (ORCL) stock fell 3% after a force majeure notice on its Project Jupiter data center and rising bond market pressure.